Literature DB >> 1356246

Neurochemical changes associated with the action of acute administration of diazepam in reversing the behavioral paradigm conditioned emotional response (CER).

J D Lane1.   

Abstract

Neurotransmitter turnover of biogenic monoamines (dopamine, norepinephrine, and serotonin) and amino acids (glutamate, aspartate, and gamma-aminobutyric acid) was evaluated in rats exposed to the conditioned emotional response (CER) paradigm in the absence (total suppression) or presence of acute 5 mg/kg i.p. diazepam (which reversed suppression and restored normal responding). Based on previous studies of CER, with controls for shock and stimulus histories, the results with respect to the anxiolytic could be divided into several categories: changes in turnover which are associated only with the CER behavior; changes associated only with the drug, diazepam; changes which augmented the effects of the behavior; or changes which were the reverse of those associated with the behavior. Due to the multitude and complexity of the results, not all observations have clear explanations at this time. However, for the CER behavior per se, it is apparent that a combination of neurotransmitters, including some implications about acetylcholine, act in concert to bring about the behavioral suppression. The action of diazepam is more complex, involving the full spectrum of neurotransmitters to bring about its direct and indirect effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356246     DOI: 10.1007/bf00969898

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  75 in total

Review 1.  Molecular biology of 5-HT receptors.

Authors:  P R Hartig
Journal:  Trends Pharmacol Sci       Date:  1989-02       Impact factor: 14.819

Review 2.  Molecular mechanisms in the receptor action of benzodiazepines.

Authors:  E Costa; A Guidotti
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

3.  Neuronal discharge patterns in concitioned emotional response.

Authors:  M Umemoto; Y Murai; M Kodama; R Kido
Journal:  Brain Res       Date:  1970-12-01       Impact factor: 3.252

4.  Potentiation by intraventricular muscimol of the anticonflict effect of benzodiazepines.

Authors:  A R Cananzi; E Costa; A Guidotti
Journal:  Brain Res       Date:  1980-09-08       Impact factor: 3.252

Review 5.  Molecular biology of GABAA receptors.

Authors:  R W Olsen; A J Tobin
Journal:  FASEB J       Date:  1990-03       Impact factor: 5.191

6.  Changes in biogenic amine and benzodiazepine receptors correlated with conditioned emotional response and its reversal by diazepam.

Authors:  J D Lane; C M Crenshaw; G F Guerin; D R Cherek; J E Smith
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

7.  Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry.

Authors:  W S Young; D Niehoff; M J Kuhar; B Beer; A S Lippa
Journal:  J Pharmacol Exp Ther       Date:  1981-02       Impact factor: 4.030

8.  Stress-induced alterations in metabolism of gamma-aminobutyric acid in rat brain.

Authors:  Y Yoneda; K Kanmori; S Ida; K Kuriyama
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

9.  Interruption of projections from the medial geniculate body to an archi-neostriatal field disrupts the classical conditioning of emotional responses to acoustic stimuli.

Authors:  J E LeDoux; A Sakaguchi; J Iwata; D J Reis
Journal:  Neuroscience       Date:  1986-03       Impact factor: 3.590

Review 10.  Receptors for the age of anxiety: pharmacology of the benzodiazepines.

Authors:  J F Tallman; S M Paul; P Skolnick; D W Gallager
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

View more
  1 in total

1.  Differential effects of MPEP and diazepam in tests of conditioned emotional response and Pavlovian-to-instrumental transfer suggests 'anxiolytic' effects are mediated by different mechanisms.

Authors:  S A George; P H Hutson; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  2009-02-11       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.